K

A

KIM , Ah Young

Last name: KIM

First name: Ah Young

February 2022 (v1)

Journal article

Metadata-only

Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database

Jung, Se Yong Kim, Min Seo Li, Han

On October 2020, the US Food and Drug Administration (FDA) approved remdesivir as the first drug for the treatment of coronavirus disease 2019 (COVID-19), increasing remdesivir prescriptions worldwide. However, potential cardiovascular (CV) toxicities associated with remdesivir remain unknown. We aimed to characterize the CV adverse drug...

Uploaded on: March 25, 2023